These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 8633831)
21. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Nestaas E; Bangstad HJ; Sandvik L; Wathne KO Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F294-300. PubMed ID: 15857879 [TBL] [Abstract][Full Text] [Related]
22. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? Barclay ML; Kirkpatrick CM; Begg EJ Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956 [TBL] [Abstract][Full Text] [Related]
23. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing. Kim MJ; Bertino JS; Erb TA; Jenkins PL; Nafziger AN J Clin Pharmacol; 2004 Jul; 44(7):696-707. PubMed ID: 15199074 [TBL] [Abstract][Full Text] [Related]
24. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. Koo J; Tight R; Rajkumar V; Hawa Z Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358 [TBL] [Abstract][Full Text] [Related]
25. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. Munckhof WJ; Grayson ML; Turnidge JD J Antimicrob Chemother; 1996 Apr; 37(4):645-63. PubMed ID: 8722531 [TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Ali MZ; Goetz MB Clin Infect Dis; 1997 May; 24(5):796-809. PubMed ID: 9142772 [TBL] [Abstract][Full Text] [Related]
27. Mega-analysis of meta-analysis: an examination of meta-analysis with an emphasis on once-daily aminoglycoside comparative trials. Freeman CD; Strayer AH Pharmacotherapy; 1996; 16(6):1093-102. PubMed ID: 8947983 [TBL] [Abstract][Full Text] [Related]
28. Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone. ter Braak EW; de Vries PJ; Bouter KP; van der Vegt SG; Dorrestein GC; Nortier JW; van Dijk A; Verkooyen RP; Verbrugh HA Am J Med; 1990 Jul; 89(1):58-66. PubMed ID: 2195890 [TBL] [Abstract][Full Text] [Related]
29. Alternative dosing strategy for aminoglycosides: impact on efficacy, nephrotoxicity, and ototoxicity. Chan GL DICP; 1989 Oct; 23(10):788-94. PubMed ID: 2683419 [TBL] [Abstract][Full Text] [Related]
30. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Feagan BG; Macdonald JK Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889 [TBL] [Abstract][Full Text] [Related]
31. Extended dosage intervals for aminoglycosides. Rodman DP; Maxwell AJ; McKnight JT Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422 [TBL] [Abstract][Full Text] [Related]
32. Single daily dose therapy with aminoglycosides. Nordström L; Lerner SA J Hosp Infect; 1991 Jun; 18 Suppl A():117-29. PubMed ID: 1679774 [TBL] [Abstract][Full Text] [Related]
33. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring. Croes S; Koop AH; van Gils SA; Neef C Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306 [TBL] [Abstract][Full Text] [Related]